# ARISE: A Phase 3 randomized trial of erenumab for episodic migraine

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/arise-a-phase-3-randomized-trial-of-erenumab-for-episodic-migraine/

## Facts

| Field | Value |
| --- | --- |
| Author Names | David W. Dodick,Messoud Ashina,Jan Lewis Brandes,David Kudrow,Michel Lantéri‐Minet,V. В. Osipova,Kerry Palmer,Hernàn Picard,Daniel D. Mikol,Robert Lenz |
| Citations | 594 |
| DOI | 10.1177/0333102418759786 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2792811290 |
| PMID | 29471679 |
| Type | article |
| Year | 2018 |

## Paper authors

- [David W. Dodick](https://scholariq.org/researchers/david-w-dodick/)

## Paper journal

- [Cephalalgia](https://scholariq.org/journals/cephalalgia/)

## Paper primary topic

- [Migraine and Headache Studies](https://scholariq.org/topics/migraine-and-headache-studies/)

## Paper topics

- [Migraine and Headache Studies](https://scholariq.org/topics/migraine-and-headache-studies/)
- [Sympathectomy and Hyperhidrosis Treatments](https://scholariq.org/topics/sympathectomy-and-hyperhidrosis-treatments/)
- [Trigeminal Neuralgia and Treatments](https://scholariq.org/topics/trigeminal-neuralgia-and-treatments/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.